NASDAQ · Biotechnology

BCTX (BCTX) Stock

$3.57 -1.65% NASDAQ: BCTX Healthcare

Valuation

MetricValue
Price$3.57
Market Cap$31.06M
P/E Ratio-0.04
P/B Ratio0.29
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$31.60
52-Week Low$2.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-144.00%
ROA-120.00%
ROCE-158.33%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio5.40

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-9.0M$-20.0M$-31.0M$-46.0M$-38.0M
Net Profit$-17.0M$-34.0M$-27.0M$-7.0M$-36.0M
EPS$-585.01$-330.38$-261.86$-59.69$-86.25
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$73.0M$55.0M$36.0M$8.0M$30.0M
Total Liabilities$38.0M$41.0M$41.0M$12.0M$6.0M
Cash$72.0M$53.0M$28.0M$1.0M$14.0M
Borrowings$0$0$0$0$0

Latest News

BriaCell Opens First Canadian Site For Phase 3 Metastatic Breast Cancer Study MT Newswires · Jul 16, 2026 BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer GlobeNewswire · Jul 16, 2026 BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™ GlobeNewswire · Jul 15, 2026 BriaCell Engages Consulting and Branding Firms to Support Potential Commercialization of Bria-IMT MT Newswires · Jul 7, 2026 BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™ GlobeNewswire · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-10.0M$-16.0M$-32.0M$-33.0M$-39.0M
Investing Cash Flow$0$0$0$-2.0M$-11.0M
Financing Cash Flow$0$-13.0M$0$0$0
Net Cash Flow$72.0M$-21.0M$-26.0M$-28.0M$13.0M
Free Cash Flow$-10.0M$-16.0M$-32.0M$-34.0M$-39.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-466.42%
Quick Ratio10.19
Interest Coverage—
Return 1Y-48.83%
Return 3Y-93.89%
Return 5Y-91.72%

Ownership

Insiders Held0.51%
Institutions Held5.25%
Institutions Float Held5.27%
Institutional HolderSharesReport Date
Cable Car Capital, LP216,8212026-03-31
Sabby Management, LLC73,9152026-03-31
Iridian Asset Management LLC65,0002026-03-31
Luminarx Capital Management LP15,0002026-03-31
UBS Group AG11,5412026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLR $1.41 -0.70% -1.91 $22.43M 0.00%
ASBP $9.21 +3.31% -0.74 $1.06M 0.00%
CRIS $1.38 -2.82% -0.35 $2.69M 0.00%
CTXR $0.58 +1.83% -0.68 $6.48M 0.00%
ENTOEntero Therapeutics, Inc. $2.85 -5.00% -0.82 $13.58M 0.00%

About BCTX

BCTX is led by CEO William V. Williams, employs 16 people, headquartered in CA, publicly traded since 2012.

BCTX stock trades at $3.57 with a market capitalization of $31.06M. The stock is valued at a price-to-earnings (P/E) ratio of -0.04, price-to-book of 0.29, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.60 and $31.60, and currently trades 88.7% below its 52-week high.

On profitability, BCTX generates a return on equity (ROE) of -144.00%, return on capital employed of -158.33%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides